Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.
Drummond MW, Heaney N, Kaeda J, Nicolini FE, Clark RE, Wilson G, Shepherd P, Tighe J, McLintock L, Hughes T, Holyoake TL. Drummond MW, et al. Among authors: shepherd p. Leukemia. 2009 Jun;23(6):1199-201. doi: 10.1038/leu.2009.43. Epub 2009 Mar 5. Leukemia. 2009. PMID: 19262595 Clinical Trial. No abstract available.
Not so NICE for CML.
Goldman J, Apperley J, Clark R, Green T, Holyoake T, O'Brien S, Shepherd P. Goldman J, et al. Among authors: shepherd p. Lancet. 2002 Jun 8;359(9322):2036. doi: 10.1016/S0140-6736(02)08796-2. Lancet. 2002. PMID: 12076575 No abstract available.
Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed.
Ibrahim AR, Clark RE, Holyoake TL, Byrne J, Shepherd P, Apperley JF, Milojkovic D, Szydlo R, Goldman J, Marin D. Ibrahim AR, et al. Among authors: shepherd p. Haematologica. 2011 Dec;96(12):1779-82. doi: 10.3324/haematol.2011.049759. Epub 2011 Aug 22. Haematologica. 2011. PMID: 21859733 Free PMC article. Clinical Trial.
Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.
Gallipoli P, Shepherd P, Irvine D, Drummond M, Holyoake T. Gallipoli P, et al. Among authors: shepherd p. Br J Haematol. 2011 Oct;155(1):128-30. doi: 10.1111/j.1365-2141.2011.08653.x. Epub 2011 Apr 22. Br J Haematol. 2011. PMID: 21517814 Free article. No abstract available.
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Milojkovic D, Nicholson E, Apperley JF, Holyoake TL, Shepherd P, Drummond MW, Szydlo R, Bua M, Foroni L, Reid A, Khorashad JS, de Lavallade H, Rezvani K, Paliompeis C, Goldman JM, Marin D. Milojkovic D, et al. Among authors: shepherd p. Haematologica. 2010 Feb;95(2):224-31. doi: 10.3324/haematol.2009.012781. Epub 2009 Oct 14. Haematologica. 2010. PMID: 19833633 Free PMC article.
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
Hochhaus A, Reiter A, Saussele S, Reichert A, Emig M, Kaeda J, Schultheis B, Berger U, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: shepherd pc. Blood. 2000 Jan 1;95(1):62-6. Blood. 2000. PMID: 10607685 Free article. Clinical Trial.
Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.
Bumm T, Müller C, Al-Ali HK, Krohn K, Shepherd P, Schmidt E, Leiblein S, Franke C, Hennig E, Friedrich T, Krahl R, Niederwieser D, Deininger MW. Bumm T, et al. Among authors: shepherd p. Blood. 2003 Mar 1;101(5):1941-9. doi: 10.1182/blood-2002-07-2053. Epub 2002 Oct 31. Blood. 2003. PMID: 12411298 Free article.
Spontaneous clinical regression in chronic lymphocytic leukaemia.
Thomas R, Ribeiro I, Shepherd P, Johnson P, Cook M, Lakhani A, Kaczmarski R, Carrington P, Catovsky D. Thomas R, et al. Among authors: shepherd p. Br J Haematol. 2002 Feb;116(2):341-5. Br J Haematol. 2002. PMID: 11841436 Free article.
363 results